Benjamin D'Alessio

Benjamin D'Alessio is currently the Director at Polynoma, leading USP CMC, tech transfer, and process development activities for Phase 3 drug substance manufacturing. Prior to this role, Benjamin held positions at Emergent BioSolutions, Lonza, AstraZeneca, and MedImmune, where Benjamin gained experience in bioprocess development, technology transfer, and cell culture studies. Benjamin holds a Master of Science in Chemical Engineering from the University of Maryland Baltimore County and a Bachelor of Science in Biochemical Engineering.